Greg Dombal

Greg Dombal is a seasoned professional in regulatory affairs and clinical operations with extensive leadership experience across various organizations. Currently serving as President of DLRC Inc., Greg has held prominent roles including Chief Development Officer and Head of Regulatory at Anji Pharma, as well as President and Chief Operating Officer at Halloran Consulting Group, Inc. Previous positions also include Sr. Director of Regulatory Affairs and Clinical Operations at ArQule and Director of Regulatory Affairs at Parexel. Greg Dombal holds a Bachelor of Science degree in Biology from the University of North Carolina at Chapel Hill, obtained between 1990 and 1994.